These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30595522)

  • 21. Stereotactic radiosurgery for intraventricular brain metastases.
    Farnia B; Voong KR; Brown PD; Allen PK; Guha-Thakurta N; Prabhu SS; Rao G; Wang Q; Zhao Z; Mahajan A
    J Neurosurg; 2014 Dec; 121 Suppl():26-34. PubMed ID: 25434934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective Study of Metastatic Melanoma and Renal Cell Carcinoma to the Brain with Multivariate Analysis of Prognostic Pre-Treatment Clinical Factors.
    Ferrel EA; Roehrig AT; Kaya EA; Carlson JD; Ling BC; Wagner A; MacKay AR; Call JA; Demakas JJ; Lamoreaux WT; Fairbanks RK; Cooke BS; Peressini B; Lee CM
    Int J Mol Sci; 2016 Mar; 17(3):400. PubMed ID: 26999120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LINAC-based radiosurgery for melanoma, sarcoma and renal cell carcinoma brain metastases.
    Maranzano E; Casale M; Rispoli R; Trippa F; Draghini L; Arcidiacono F; Carletti S; Anselmo P
    J Neurosurg Sci; 2020 Feb; 64(1):37-43. PubMed ID: 27603406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
    Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
    J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases.
    Bowman IA; Bent A; Le T; Christie A; Wardak Z; Arriaga Y; Courtney K; Hammers H; Barnett S; Mickey B; Patel T; Whitworth T; Stojadinovic S; Hannan R; Nedzi L; Timmerman R; Brugarolas J
    Clin Genitourin Cancer; 2019 Apr; 17(2):e263-e272. PubMed ID: 30538068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone.
    Farris M; McTyre ER; Cramer CK; Hughes R; Randolph DM; Ayala-Peacock DN; Bourland JD; Ruiz J; Watabe K; Laxton AW; Tatter SB; Zhou X; Chan MD
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):131-141. PubMed ID: 28586952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study.
    Yamamoto M; Serizawa T; Higuchi Y; Nagano O; Aiyama H; Koiso T; Watanabe S; Kawabe T; Sato Y; Kasuya H
    J Neurosurg; 2018 Dec; 129(Suppl1):95-102. PubMed ID: 30544299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma.
    Muacevic A; Kreth FW; Mack A; Tonn JC; Wowra B
    Minim Invasive Neurosurg; 2004 Aug; 47(4):203-8. PubMed ID: 15346315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy.
    Ahmed KA; Stallworth DG; Kim Y; Johnstone PA; Harrison LB; Caudell JJ; Yu HH; Etame AB; Weber JS; Gibney GT
    Ann Oncol; 2016 Mar; 27(3):434-41. PubMed ID: 26712903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.
    Patel KR; Burri SH; Boselli D; Symanowski JT; Asher AL; Sumrall A; Fraser RW; Press RH; Zhong J; Cassidy RJ; Olson JJ; Curran WJ; Shu HG; Crocker IR; Prabhu RS
    J Neurooncol; 2017 Feb; 131(3):611-618. PubMed ID: 28000105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Brain Metastases.
    Lehrer EJ; Kowalchuk RO; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Harmsen WS; Jones BM; Sharma S; Ahluwalia MS; Sheehan JP; Trifiletti DM
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):858-868. PubMed ID: 36690161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
    J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery.
    Ma J; Del Balzo L; Walch H; Khaleel S; Knezevic A; Flynn J; Zhang Z; Eichholz J; Doshi SD; Voss MH; Freeman B; Ari Hakimi A; Lee CH; Bale TA; Kelly D; Mueller BA; Mann J; Yu Y; Zinovoy M; Chen L; Cuaron J; Khan A; Yamada Y; Shin JY; Beal K; Moss NS; Carlo MI; Motzer RJ; Imber BS; Kotecha RR; Pike LRG
    Eur Urol Oncol; 2024 Aug; ():. PubMed ID: 39107179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases.
    Uezono H; Nam D; Kluger HM; Sznol M; Hurwitz M; Yu JB; Chiang VL
    Am J Clin Oncol; 2021 Sep; 44(9):495-501. PubMed ID: 34432667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
    Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
    Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients.
    Yomo S; Hayashi M
    BMC Cancer; 2015 Mar; 15():95. PubMed ID: 25879433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.